The promigratory activity of the matricellular protein galectin-3 depends on the activation of pi-3 kinase

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Melo, Fabiana H M ^a   Butera, Diego ^a,b   de Junqueira, Mara Souza ^a   Hsu, Daniel K ^c   da Silva, Ana Maria Moura ^b   Liu, Fu Tong ^c   Santos, Marinilice F ^a   Chammas, Roger ^a,d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Instituto do Cancer do Estado de Sao Paulo   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; FOCAL ADHESION KINASE; GALECTIN 3; INTEGRIN; LAMININ; LAMININ 111; PAXILLIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE PHOSPHATASE SHP 2; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; EXTRACELLULAR SPACE; FOCAL ADHESION; LAMELLIPODIUM; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; SARCOMA CELL; ANIMAL; CELL STRAIN 3T3; ENZYME ACTIVATION; GENETICS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE;

MUS;

ANIMALS; ENZYME ACTIVATION; GALECTIN 3; MICE; NIH 3T3 CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 84555205242     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029313     Document Type: Article

References (83)

1. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
2. Hood JD, Cheresh DA, (2002) Role of integrins in cell invasion and migration. Nat Rev Cancer 2: 91-100.
3. Aumailley M, Bruckner-Tuderman L, Carter WG, Deutzmann R, Edgar D, et al. (2005) A simplified laminin nomenclature. Matrix Biol 24: 326-332.
4. Jasiulionis MG, Chammas R, Ventura AM, Travassos LR, Brentani RR, (1996) alpha6beta1-Integrin, a major cell surface carrier of beta1-6-branched oligosaccharides, mediates migration of EJ-ras-transformed fibroblasts on laminin-1 independently of its glycosylation state. Cancer Res 56: 1682-1689.
5. Wehrle-Haller B, Imhof BA, (2003) Integrin-dependent pathologies. J Pathol 200: 481-487.
6. Bellis SL, (2004) Variant glycosylation: an underappreciated regulatory mechanism for beta1 integrins. Biochim Biophys Acta 1663: 52-60.
7. Chammas R, Veiga SS, Travassos LR, Brentani RR, (1993) Functionally distinct roles for glycosylation of alpha and beta integrin chains in cell-matrix interactions. Proc Natl Acad Sci U S A 90: 1795-1799.
8. Veiga SS, Chammas R, Cella N, Brentani RR, (1995) Glycosylation of beta-1 integrins in B16-F10 mouse melanoma cells as determinant of differential binding and acquisition of biological activity. Int J Cancer 61: 420-424.
9. Guo HB, Lee I, Kamar M, Akiyama SK, Pierce M, (2002) Aberrant N-glycosylation of beta1 integrin causes reduced alpha5beta1 integrin clustering and stimulates cell migration. Cancer Res 62: 6837-6845.
10. Granovsky M, Fata J, Pawling J, Muller WJ, Khokha R, et al. (2000) Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med 6: 306-312.
11. Hirabayashi J, Hashidate T, Arata Y, Nishi N, Nakamura T, et al. (2002) Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim Biophys Acta 1572: 232-254.
12. de Melo FH, Butera D, Medeiros RS, Andrade LN, Nonogaki S, et al. (2007) Biological applications of a chimeric probe for the assessment of galectin-3 ligands. J Histochem Cytochem 55: 1015-1026.
13. Liu FT, Rabinovich GA, (2005) Galectins as modulators of tumour progression. Nat Rev Cancer 5: 29-41.
14. Gong HC, Honjo Y, Nangia-Makker P, Hogan V, Mazurak N, et al. (1999) The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells. Cancer Res 59: 6239-6245.
15. Lindstedt R, Apodaca G, Barondes SH, Mostov KE, Leffler H, (1993) Apical secretion of a cytosolic protein by Madin-Darby canine kidney cells. Evidence for polarized release of an endogenous lectin by a nonclassical secretory pathway. J Biol Chem 268: 11750-11757.
16. Sato S, Ouellet N, Pelletier I, Simard M, Rancourt A, et al. (2002) Role of galectin-3 as an adhesion molecule for neutrophil extravasation during streptococcal pneumonia. J Immunol 168: 1813-1822.
17. Schafer T, Zentgraf H, Zehe C, Brugger B, Bernhagen J, et al. (2004) Unconventional secretion of fibroblast growth factor 2 is mediated by direct translocation across the plasma membrane of mammalian cells. J Biol Chem 279: 6244-6251.
18. Baptiste TA, James A, Saria M, Ochieng J, (2007) Mechano-transduction mediated secretion and uptake of galectin-3 in breast carcinoma cells: implications in the extracellular functions of the lectin. Exp Cell Res 313: 652-664.
19. Nangia-Makker P, Balan V, Raz A, (2008) Regulation of tumor progression by extracellular galectin-3. Cancer Microenviron 1: 43-51.
20. Bornstein P, Sage EH, (2002) Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol 14: 608-616.
21. Danguy A, Camby I, Kiss R, (2002) Galectins and cancer. Biochim Biophys Acta 1572: 285-293.
22. Khanna C, Khan J, Nguyen P, Prehn J, Caylor J, et al. (2001) Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res 61: 3750-3759.
23. Neder L, Marie SK, Carlotti CG Jr, Gabbai AA, Rosemberg S, et al. (2004) Galectin-3 as an immunohistochemical tool to distinguish pilocytic astrocytomas from diffuse astrocytomas, and glioblastomas from anaplastic oligodendrogliomas. Brain Pathol 14: 399-405.
24. Carpi A, Mechanick JI, Saussez S, Nicolini A, (2010) Thyroid tumor marker genomics and proteomics: diagnostic and clinical implications. J Cell Physiol 224: 612-619.
25. Hao X, Fredrickson TN, Chattopadhyay SK, Han W, Qi CF, et al. (2010) The histopathologic and molecular basis for the diagnosis of histiocytic sarcoma and histiocyte-associated lymphoma of mice. Vet Pathol 47: 434-445.
26. Califice S, Castronovo V, Bracke M, Van Den Brule F, (2004) Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3. Oncogene 23: 7527-7536.
27. Grassadonia A, Tinari N, Iurisci I, Piccolo E, Cumashi A, et al. (2004) 90 K (Mac-2 BP) and galectins in tumor progression and metastasis. Glycoconj J 19: 551-556.
28. Nakamura M, Inufusa H, Adachi T, Aga M, Kurimoto M, et al. (1999) Involvement of galectin-3 expression in colorectal cancer progression and metastasis. Int J Oncol 15: 143-148.
29. Jensen-Jarolim E, Gscheidlinger R, Oberhuber G, Neuchrist C, Lucas T, et al. (2002) The constitutive expression of galectin-3 is downregulated in the intestinal epithelia of Crohn's disease patients, and tumour necrosis factor alpha decreases the level of galectin-3-specific mRNA in HCT-8 cells. Eur J Gastroenterol Hepatol 14: 145-152.
30. Gray RM, Davis MJ, Ruby KM, Voss PG, Patterson RJ, et al. (2008) Distinct effects on splicing of two monoclonal antibodies directed against the amino-terminal domain of galectin-3. Arch Biochem Biophys 475: 100-108.
31. Qin Z, Kim HJ, Hemme J, Blankenstein T, (2002) Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reaction. J Exp Med 195: 1479-1490.
32. Goetz JG, (2009) Bidirectional control of the inner dynamics of focal adhesions promotes cell migration. Cell Adh Migr 3: 185-190 7295.
33. Broussard JA, Webb DJ, Kaverina I, (2008) Asymmetric focal adhesion disassembly in motile cells. Curr Opin Cell Biol 20: 85-90.
34. Rafiq K, Kolpakov MA, Abdelfettah M, Streblow DN, Hassid A, et al. (2006) Role of protein-tyrosine phosphatase SHP2 in focal adhesion kinase down-regulation during neutrophil cathepsin G-induced cardiomyocytes anoikis. J Biol Chem 281: 19781-19792.
35. Tsutsumi R, Takahashi A, Azuma T, Higashi H, Hatakeyama M, (2006) Focal adhesion kinase is a substrate and downstream effector of SHP-2 complexed with Helicobacter pylori CagA. Mol Cell Biol 26: 261-276.
36. Schaller MD, Parsons JT, (1995) pp125FAK-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk. Mol Cell Biol 15: 2635-2645.
37. Bellis SL, Miller JT, Turner CE, (1995) Characterization of tyrosine phosphorylation of paxillin in vitro by focal adhesion kinase. J Biol Chem 270: 17437-17441.
38. Hall A, (1998) Rho GTPases and the actin cytoskeleton. Science 279: 509-514.
39. Manser E, Leung T, Salihuddin H, Zhao ZS, Lim L, (1994) A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 367: 40-46 10.1038/367040a0 [doi].
40. Saravanan C, Liu FT, Gipson IK, Panjwani N, (2009) Galectin-3 promotes lamellipodia formation in epithelial cells by interacting with complex N-glycans on alpha3beta1 integrin. J Cell Sci 122: 3684-3693.
41. Keely PJ, Westwick JK, Whitehead IP, Der CJ, Parise LV, (1997) Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature 390: 632-636.
42. Kawachi K, Matsushita Y, Yonezawa S, Nakano S, Shirao K, et al. (2000) Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation. Hum Pathol 31: 428-433.
43. Openo KP, Kadrofske MM, Patterson RJ, Wang JL, (2000) Galectin-3 expression and subcellular localization in senescent human fibroblasts. Exp Cell Res 255: 278-290.
44. Hebert E, Monsigny M, (1994) Galectin-3 mRNA level depends on transformation phenotype in ras-transformed NIH 3T3 cells. Biol Cell 81: 73-76.
45. Inohara H, Akahani S, Raz A, (1998) Galectin-3 stimulates cell proliferation. Exp Cell Res 245: 294-302.
46. Bresalier RS, Yan PS, Byrd JC, Lotan R, Raz A, (1997) Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system. Cancer 80: 776-787.
47. Brat DJ, Castellano-Sanchez AA, Hunter SB, Pecot M, Cohen C, et al. (2004) Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res 64: 920-927.
48. Villa-Verde DM, Silva-Monteiro E, Jasiulionis MG, Farias-De-Oliveira DA, Brentani RR, et al. (2002) Galectin-3 modulates carbohydrate-dependent thymocyte interactions with the thymic microenvironment. Eur J Immunol 32: 1434-1444.
49. Silva-Monteiro E, Reis LL, Kenji NO, Junqueira M, Rabinovich GA, et al. (2007) Altered expression of galectin-3 induces cortical thymocyte depletion and premature exit of immature thymocytes during Trypanosoma cruzi infection. Am J Pathol 170: 546-556.
50. Kariya Y, Kawamura C, Tabei T, Gu J, (2010) Bisecting GlcNAc residues on laminin-332 down-regulate galectin-3-dependent keratinocyte motility. J Biol Chem 285: 3330-3340.
51. Nickel W, (2003) The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur J Biochem 270: 2109-2119.
52. Hughes RC, (1999) Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim Biophys Acta 1473: 172-185.
53. Lukyanov P, Furtak V, Ochieng J, (2005) Galectin-3 interacts with membrane lipids and penetrates the lipid bilayer. Biochem Biophys Res Commun 338: 1031-1036.
54. Zhuo Y, Chammas R, Bellis SL, (2008) Sialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis. J Biol Chem.
55. Ochieng J, Leite-Browning ML, Warfield P, (1998) Regulation of cellular adhesion to extracellular matrix proteins by galectin-3. Biochem Biophys Res Commun 246: 788-791.
56. Friedrichs J, Manninen A, Muller DJ, Helenius J, (2008) Galectin-3 regulates integrin alpha2beta1-mediated adhesion to collagen-I and-IV. J Biol Chem 283: 32264-32272.
57. Zhu WQ, Ochieng J, (2001) Rapid release of intracellular galectin-3 from breast carcinoma cells by fetuin. Cancer Res 61: 1869-1873.
58. Sano H, Hsu DK, Yu L, Apgar JR, Kuwabara I, et al. (2000) Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J Immunol 165: 2156-2164.
59. Cao Z, Said N, Amin S, Wu HK, Bruce A, et al. (2002) Galectins-3 and-7, but not galectin-1, play a role in re-epithelialization of wounds. J Biol Chem 277: 42299-42305.
60. Laudanna C, Kim JY, Constantin G, Butcher E, (2002) Rapid leukocyte integrin activation by chemokines. Immunol Rev 186: 37-46.
61. Markowska AI, Liu FT, Panjwani N, (2010) Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response. J Exp Med 207: 1981-1993.
62. Furtak V, Hatcher F, Ochieng J, (2001) Galectin-3 mediates the endocytosis of beta-1 integrins by breast carcinoma cells. Biochem Biophys Res Commun 289: 845-850.
63. Lagana A, Goetz JG, Cheung P, Raz A, Dennis JW, et al. (2006) Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells. Mol Cell Biol 26: 3181-3193.
64. Goetz JG, Joshi B, Lajoie P, Strugnell SS, Scudamore T, et al. (2008) Concerted regulation of focal adhesion dynamics by galectin-3 and tyrosine-phosphorylated caveolin-1. J Cell Biol 180: 1261-1275.
65. Hsia DA, Mitra SK, Hauck CR, Streblow DN, Nelson JA, et al. (2003) Differential regulation of cell motility and invasion by FAK. J Cell Biol 160: 753-767.
66. Guvakova MA, Surmacz E, (1999) The activated insulin-like growth factor I receptor induces depolarization in breast epithelial cells characterized by actin filament disassembly and tyrosine dephosphorylation of FAK, Cas, and paxillin. Exp Cell Res 251: 244-255.
67. Guo HB, Randolph M, Pierce M, (2007) Inhibition of a specific N-glycosylation activity results in attenuation of breast carcinoma cell invasiveness-related phenotypes: inhibition of epidermal growth factor-induced dephosphorylation of focal adhesion kinase. J Biol Chem 282: 22150-22162.
68. Brown MC, Turner CE, (2004) Paxillin: adapting to change. Physiol Rev 84: 1315-1339.
69. Tolias KF, Cantley LC, Carpenter CL, (1995) Rho family GTPases bind to phosphoinositide kinases. J Biol Chem 270: 17656-17659.
70. Kwon M, Ling Y, Maile LA, Badley-Clark J, Clemmons DR, (2006) Recruitment of the tyrosine phosphatase Src homology 2 domain tyrosine phosphatase-2 to the p85 subunit of phosphatidylinositol-3 (PI-3) kinase is required for insulin-like growth factor-I-dependent PI-3 kinase activation in smooth muscle cells. Endocrinology 147: 1458-1465.
71. Murphy-Ullrich JE, (2001) The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? J Clin Invest 107: 785-790.
72. Jones PL, Jones FS, (2000) Tenascin-C in development and disease: gene regulation and cell function. Matrix Biol 19: 581-596.
73. Bornstein P, (2001) Thrombospondins as matricellular modulators of cell function. J Clin Invest 107: 929-934.
74. Brekken RA, Sage EH, (2000) SPARC, a matricellular protein: at the crossroads of cell-matrix. Matrix Biol 19: 569-580.
75. Levy Y, Arbel-Goren R, Hadari YR, Eshhar S, Ronen D, et al. (2001) Galectin-8 functions as a matricellular modulator of cell adhesion. J Biol Chem 276: 31285-31295.
76. Ahmad N, Gabius HJ, Andre S, Kaltner H, Sabesan S, et al. (2004) Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes. J Biol Chem 279: 10841-10847.
77. Lajoie P, Nabi IR, (2007) Regulation of raft-dependent endocytosis. J Cell Mol Med 11: 644-653.
78. Demetriou M, Granovsky M, Quaggin S, Dennis JW, (2001) Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409: 733-739.
79. Lau KS, Partridge EA, Grigorian A, Silvescu CI, Reinhold VN, et al. (2007) Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 129: 123-134.
80. Hsu DK, Yang RY, Pan Z, Yu L, Salomon DR, et al. (2000) Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol 156: 1073-1083.
81. Iglesias MM, Rabinovich GA, Ambrosio AL, Castagna LF, Sotomayor CE, et al. (1998) Purification of galectin-3 from ovine placenta: developmentally regulated expression and immunological relevance. Glycobiology 8: 59-65.
82. Avnur Z, Geiger B, (1981) Substrate-attached membranes of cultured cells isolation and characterization of ventral cell membranes and the associated cytoskeleton. J Mol Biol 153: 361-379.
83. Lampugnani MG, (1999) Cell migration into a wounded area in vitro. Methods Mol Biol 96: 177-182.